Michael Muller

Prof. Dr. Michael Muller

Nutrigenomics and Systems Nutrition Group, Norwich Medical School, BMRC, University of East Anglia, Norwich NR4 7UQ, UK
orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2004 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
SMStéphane MANDARD
Stéphane MANDARD
MMMichael Muller
Michael Muller
SKS. Kersten
S. Kersten

26 September 2010 in PPAR Research
Verified
Journal Article
Open access
PDF file
MRMaryam Rakhshandehroo
Maryam Rakhshandehroo
BKBianca Knoch
Bianca Knoch
MMMichael Muller
Michael Muller
SKSander Kersten
Sander Kersten
The peroxisome proliferator-activated receptor alpha (PPARα) is a ligand-activated transcription factor involved in the regulation of a variety of processes, ranging from inflammation and immunity to nutrient metabolism and energy homeostasis. PPARαserves as a molecular target for hypolipidemic fibrates drugs which bind the receptor with high affinity. Furthermore, PPARαbinds and is activated by numerous fatty acids and fatty acid-derived compounds. PPARαgoverns biological processes by altering the expression of a large number of target genes. Accordingly, the specific role of PPARαis directly related to the biological function of its target genes. Here, we present an overview of the involvement of PPARαin lipid metabolism and other pathways through a detailed analysis of the different known or putative PPARαtarget genes. The emphasis is on gene regulation by PPARαin liver although many of the results likely apply to other organs and tissues as well.

1 December 2010 in Cell Metabolism
Verified
Journal Article
Closed access
RSRinke Stienstra
Rinke Stienstra
LJLeo A.B. Joosten
Leo A.B. Joosten
TKTim Koenen
Tim Koenen
BTBerry van Tits
Berry van Tits
JDJanna A. van Diepen
Janna A. van Diepen
MNMihai G. Netea
Mihai G. Netea

15 December 2013 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Open access
PDF file
GBGijs Den Besten
Gijs Den Besten
KLKatja Lange
Katja Lange
RHRick Havinga
Rick Havinga
TDTheo H. van Dijk
Theo H. van Dijk
AGAlbert Gerding
Albert Gerding
DRDirk-Jan Reijngoud
Dirk-Jan Reijngoud
Acetate, propionate, and butyrate are the main short-chain fatty acids (SCFAs) that arise from the fermentation of fibers by the colonic microbiota. While many studies focus on the regulatory role of SCFAs, their quantitative role as a catabolic or anabolic substrate for the host has received relatively little attention. To investigate this aspect, we infused conscious mice with physiological quantities of stable isotopes [1-13C]acetate, [2-13C]propionate, or [2,4-13C2]butyrate directly in the cecum, which is the natural production site in mice, and analyzed their interconversion by the microbiota as well as their metabolism by the host. Cecal interconversion, pointing to microbial cross-feeding, was high between acetate and butyrate, low between butyrate and propionate, and almost absent between acetate and propionate. As much as 62% of infused propionate was used in whole body glucose production, in line with its role as gluconeogenic substrate. Conversely, glucose synthesis from propionate accounted for 69% of total glucose production. The synthesis of palmitate and cholesterol in the liver was high from cecal acetate (2.8 and 0.7%, respectively) and butyrate (2.7 and 0.9%, respectively) as substrates, but low or absent from propionate (0.6 and 0.0%, respectively). Label incorporation due to chain elongation of stearate was approximately eightfold higher than de novo synthesis of stearate. Microarray data suggested that SCFAs exert a mild regulatory effect on the expression of genes involved in hepatic metabolic pathways during the 6-h infusion period. Altogether, gut-derived acetate, propionate, and butyrate play important roles as substrates for glucose, cholesterol, and lipid metabolism.

1 January 2011 in Frontiers in Microbiology
Verified
Journal Article
Open access
MDMuriel Derrien
Muriel Derrien
IBIr. Peter van Baarlen
Ir. Peter van Baarlen
GHGuido Hooiveld
Guido Hooiveld
ENElisabeth Norin
Elisabeth Norin
MMMichael Muller
Michael Muller
WVWillem M De Vos
Willem M De Vos
Epithelial cells of the mammalian intestine are covered with a mucus layer that prevents direct contact with intestinal microbes but also constitutes a substrate for mucus-degrading bacteria. To study the effect of mucus degradation on the host response, germ-free mice were colonized with Akkermansia muciniphila. This anaerobic bacterium belonging to the Verrucomicrobia is specialized in the degradation of mucin, the glycoprotein present in mucus, and found in high numbers in the intestinal tract of human and other mammalian species. Efficient colonization of A. muciniphila was observed with highest numbers in the cecum, where most mucin is produced. In contrast, following colonization by Lactobacillus plantarum, a facultative anaerobe belonging to the Firmicutes that ferments carbohydrates, similar cell-numbers were found at all intestinal sites. Whereas A. muciniphila was located closely associated with the intestinal cells, L. plantarum was exclusively found in the lumen. The global transcriptional host response was determined in intestinal biopsies and revealed a consistent, site-specific, and unique modulation of about 750 genes in mice colonized by A. muciniphila and over 1500 genes after colonization by L. plantarum. Pathway reconstructions showed that colonization by A. muciniphila altered mucosal gene expression profiles toward increased expression of genes involved in immune responses and cell fate determination, while colonization by L. plantarum led to up-regulation of lipid metabolism. These indicate that the colonizers induce host responses that are specific per intestinal location. In conclusion, we propose that A. muciniphila modulates pathways involved in establishing homeostasis for basal metabolism and immune tolerance toward commensal microbiota.

1 April 2003 in Nature Reviews Genetics
Verified
Journal Article
Closed access
MMMichael Muller
Michael Muller
SKSander Kersten
Sander Kersten